EI- Nile Co. for Pharmaceuticals and Chemical Industries (EGX:NIPH)
Egypt · Delayed Price · Currency is EGP 163.00
+4.90 (3.10%)
At close: Jun 4, 2026
EGX:NIPH Revenue
EI- Nile Co. for Pharmaceuticals and Chemical Industries had revenue of 638.14M EGP in the quarter ending March 31, 2026, with 71.43% growth. This brings the company's revenue in the last twelve months to 2.24B, up 113.77% year-over-year. In the fiscal year ending June 30, 2025, EI- Nile Co. for Pharmaceuticals and Chemical Industries had annual revenue of 1.29B with 12.86% growth.
Revenue (ttm)
2.24B
Revenue Growth
+113.77%
P/S Ratio
3.64
Revenue / Employee
895.66K
Employees
2,500
Market Cap
8.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.29B | 146.99M | 12.86% |
| Jun 30, 2024 | 1.14B | 137.37M | 13.67% |
| Jun 30, 2023 | 1.01B | 128.44M | 14.65% |
| Jun 30, 2022 | 876.78M | 121.27M | 16.05% |
| Jun 30, 2021 | 755.51M | -57.02M | -7.02% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition